We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+20.52%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$10.8B
AUM Growth
+$1.42B
Cap. Flow
-$217M
Cap. Flow %
-2.01%
Top 10 Hldgs %
22.86%
Holding
302
New
45
Increased
79
Reduced
106
Closed
36

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$73.2M
2
SNPS icon
Synopsys
SNPS
+$63.3M
3
GPN icon
Global Payments
GPN
+$55.9M
4
TFX icon
Teleflex
TFX
+$54.3M
5
A icon
Agilent Technologies
A
+$47.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$160M
2
UNH icon
UnitedHealth
UNH
+$122M
3
MDT icon
Medtronic
MDT
+$90M
4
HUM icon
Humana
HUM
+$52M
5
LOXO
Loxo Oncology, Inc
LOXO
+$50M

Sector Composition

Rank Sector Weight
1 Technology 26.76%
2 Financials 21.83%
3 Healthcare 19.84%
4 Communication Services 8.39%
5 Consumer Discretionary 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALNY icon
151
Alnylam Pharmaceuticals
ALNY
$38.5B
$19.2M 0.18%
205,017
-89,270
-30% -$7.47M
GLW icon
152
Corning
GLW
$108B
$18.4M 0.17%
555,172
-62,112
-10% -$2.04M
NSTG
153
DELISTED
NanoString Technologies, Inc.
NSTG
$17.9M 0.17%
750,000
+150,000
+25% +$3.45M
PVG
154
DELISTED
PRETIUM RESOURCES INC.
PVG
$16.3M 0.15%
1,904,904
+78,274
+4% +$622K
AGI icon
155
Alamos Gold
AGI
$12.1B
$16M 0.15%
+2,650,074
New +$12.1M
WOLF icon
156
Wolfspeed
WOLF
$1.14B
$15.5M 0.14%
270,067
-38,540
-12% -$1.98M
TAK icon
157
Takeda Pharmaceutical
TAK
$56B
$15.3M 0.14%
750,000
+250,000
+50% +$5.03M
AGIO icon
158
Agios Pharmaceuticals
AGIO
$2.14B
$15.2M 0.14%
225,161
-109,839
-33% -$6.4M
HRTG icon
159
Heritage Insurance Holdings
HRTG
$905M
$14.5M 0.13%
990,000
-288,500
-23% -$4.26M
TD icon
160
Toronto Dominion Bank
TD
$199B
$14.4M 0.13%
225,249
-4,500
-2% -$249K
GRFS
161
Grifois
GRFS
$5.44B
$14.4M 0.13%
715,000
+11,630
+2% +$222K
CELG
162
DELISTED
Celgene Corp
CELG
$14.2M 0.13%
150,000
-125,000
-45% -$10.9M
GG
163
DELISTED
Goldcorp Inc
GG
$13.4M 0.12%
1,175,038
-1,314,827
-53% -$14.1M
ONC
164
BeOne Medicines Ltd
ONC
$34.3B
$13.2M 0.12%
100,000
-60,000
-38% -$8.1M
FAF icon
165
First American
FAF
$8.08B
$12.9M 0.12%
250,000
– –
KEYS icon
166
Keysight
KEYS
$52.2B
$12.9M 0.12%
147,591
– –
BDX icon
167
Becton Dickinson
BDX
$45.8B
$12.5M 0.12%
51,277
– –
PNC icon
168
PNC Financial Services
PNC
$100B
$12.2M 0.11%
99,792
-10,753
-10% -$1.33M
ARCC icon
169
Ares Capital
ARCC
$13.7B
$11.7M 0.11%
685,000
-36,732
-5% -$615K
RMD icon
170
ResMed
RMD
$30.3B
$11.4M 0.11%
110,000
– –
GKOS icon
171
Glaukos
GKOS
$8.89B
$10.6M 0.1%
+135,000
New +$9.01M
SLRC icon
172
SLR Investment Corp
SLRC
$708M
$10.4M 0.1%
498,278
-5,000
-1% -$104K
BMRN icon
173
BioMarin Pharmaceuticals
BMRN
$12B
$10.2M 0.09%
115,000
-39,370
-26% -$3.65M
BAX icon
174
Baxter International
BAX
$12.6B
$10.2M 0.09%
+125,000
New +$9.1M
FRC
175
DELISTED
First Republic Bank
FRC
$9.87M 0.09%
98,264
-1,512
-2% -$149K
5 6
7
8 9

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q1 2019 Portfolio in Review

As of Q1 2019, Polar Capital held 302 positions worth $10.8B, up 15% from $9.35B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Polar Capital's Q1 2019 filing shows 45 new, 79 increased, 106 reduced and 36 closed positions. Its largest new stake was Global Payments: 460,457 shares worth $62.9M. The largest sale was Johnson & Johnson, an estimated $160M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • Polar Capital's largest Q1 2019 buy was Global Payments: 460,457 shares worth $62.9M.
  • Polar Capital added most to Merck in Q1 2019, an estimated $73.2M increase.
  • Polar Capital's biggest Q1 2019 reduction was Johnson & Johnson, cutting an estimated $160M.
  • Polar Capital fully exited UnitedHealth in Q1 2019, selling an estimated $122M.
  • Polar Capital's ten largest holdings make up 23% of its $10.8B portfolio in Q1 2019.
  • Polar Capital opened 45 new positions and closed 36 in Q1 2019.
  • Polar Capital's portfolio value rose 15% quarter-over-quarter to $10.8B.

Based on Polar Capital's 13F filing for Q1 2019, filed 15 May 2019.